NCT00004754View on ClinicalTrials.gov

Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1993

Conditions
Hypertension, Pulmonary
Interventions
DRUG

epoprostenol

All Listed Sponsors
collaborator

Baylor College of Medicine

OTHER

lead

National Center for Research Resources (NCRR)

NIH